Mice with fibroblast-specific deletion of MMP14 were generated by crossing a mouse line with floxed MMP14 gene to mice that express the estrogen receptor inducible Cre recombinase under control a fibroblast-specific regulatory fragment of the pro-α2 (I) collagen gene, as previously described [11]. For experimental skin fibrosis, we used an established mouse protocol [21]. Control mice were treated with intradermal injections of bleomycin (100 µg) (PZN-02411351, Medac GmbH, Wedel, Germany) five days a week for five weeks. Afterward, 0.5 × 106 B16F1 cells were injected intradermally into the mice’s flank and tumor growth was followed and documented. Tumor size was measured using a precision caliper (Mitutoyo, Neuss, Germany) and mice were euthanized when they reached a maximal allowed tumor size. Tumors and organs were collected for further analysis.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.